The dissociated steroid receptor ligand from plant origin called compound A (CpdA) inhibits the production of steroid-resistant chemokines induced by TNFα/IFNγ in airway smooth muscle (ASM) cells in both asthma and healthy subjects

L. Chachi, A. Gavrila, O. Tliba, C. Brightling, Y. Amrani (Leicester, United Kingdom; Philadelphia, United States Of America)

Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Session: Molecular biology of pro- and anti-inflammatory responses in the lung
Session type: Thematic Poster Session
Number: 3709
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Chachi, A. Gavrila, O. Tliba, C. Brightling, Y. Amrani (Leicester, United Kingdom; Philadelphia, United States Of America). The dissociated steroid receptor ligand from plant origin called compound A (CpdA) inhibits the production of steroid-resistant chemokines induced by TNFα/IFNγ in airway smooth muscle (ASM) cells in both asthma and healthy subjects. Eur Respir J 2012; 40: Suppl. 56, 3709

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
TNFα stimulates the expression different chemokines including CXCl10, CCL5 and CXCL8 in developing airway smooth muscle (ASM) cells: Modulation by fluticasone and TNFα receptors
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012

Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009

Compound A (CpdA) suppressed production of corticosteroid-resistant chemokines via GR-independent mechanisms in airway smooth muscle (ASM) cells
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013

Endothelin receptor B (ETBR) dependent GM-CSF mRNA stabilization explains the higher efficacy of bosentan vs. ambrisentan in the reduction of GM-CSF release from human airway smooth muscle cells (HASMCs)
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011

Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

Endothelin receptor antagonists (ERAs) neutralize LPS-induced cytokine release from pulmonary vascular smooth muscle cells (PVSMCs) by down-regulation of CD14
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

Glutathionylation of IκB-α inhibits NF-κB dependent chemokine secretion in airway smooth muscle cells
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Compound A modulates steroid insensitive chemokines in airway smooth muscle cells via IRF-1 dependent and independent pathways
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015

A novel receptor antagonist, c-027, inhibits airway contraction in human and murine models of allergen, independent of inflammatory mediator release
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009

Heme-oxygenase (HO)-1 inhibits TNF-α induced CXCL10 secretion by airway smooth muscle cells
Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology
Year: 2011


RANTES expression induced by Toll-like receptor 3 and 4 ligands on rat airway smooth muscle cells
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009


TGFβ1 induced loss of β-adrenergic response in human bronchial smooth muscle cells (hBSMC) is dependent on TGFβ-RI kinase activity: potential therapeutic application in treating airway diseases
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003


Resveratrol is superior to dexamethasone in suppressing cytokine release from human airway smooth muscle cells exposed to lipoteichoic acid in COPD
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013


Azithromycin (AZI) inhibits the IL-17 induced IL-8 production in human airway smooth muscle cells (HASMC): a possible explanation for the beneficial effect in BOS?
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005


The PPARgamma agonist ciglitizone inhibits CXCL10 release by asthmatic and non-asthmatic airway smooth muscle cells
Source: Eur Respir J 2006; 28: Suppl. 50, 339s
Year: 2006

α-4 integrin blockade modulates airway smooth muscle (ASM) growth induced by activated, antigen-specific CD4+T cells
Source: Annual Congress 2009 - Airways remodelling
Year: 2009

IL-1β-induced MCP-1 production in human airway smooth muscle cells, modulation by dexamethasone, rolipram, and salbutamol
Source: Eur Respir J 2001; 18: Suppl. 33, 353s
Year: 2001

CRE, but not AP-1, NF-κB, or C/EBP, mediates β-agonist-induced IL-6 gene expression induced in human airway smooth muscle (HASM) cells
Source: Eur Respir J 2001; 18: Suppl. 33, 407s
Year: 2001

Involvement of protein kinase A (PKA) in the IL-1β induced MCP-1 production in human airway smooth muscle cells
Source: Eur Respir J 2001; 18: Suppl. 33, 353s
Year: 2001

Remicade suppresses cytokine-induced up-regulation of bradykinin receptor-mediated airway smooth muscle contractions
Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions
Year: 2005